Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basilar Artery International Cooperation Study (BASICS)
2010-023507-95Phase 3Active
- Sponsor
- BASICS Study Group
- Start
- Nov 2010
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of urokinase and tissue-plasminogen activator in ischemic stroke and Basilar artery thrombosis (BAT) (2 arms), sponsored by BASICS Study Group. Primary endpoint: Favorable functional outcome at 90 days. Started Nov 2010; status: active.
02
Drugs
urokinasetissue-plasminogen activator
03
Conditions
ischemic strokeBasilar artery thrombosis (BAT)
Beyond the preview
Go deeper on 2010-023507-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023507-95.